TrademarkDir
OBSIDIAN THERAPEUTICS
DEAD

Serial Number

88530962

Owner

Obsidian Therapeutics, Inc.

Attorney

Olivia Maria Baratta

Filing Date

Jul 23, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OBSIDIAN THERAPEUTICS Trademark

Serial Number: 88530962

OBSIDIAN THERAPEUTICS is a trademark filed by Obsidian Therapeutics, Inc. on July 23, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Obsidian Therapeutics, Inc. (24 trademarks)

1030 Massachusetts Avenue, Fourth Floor
Cambridge, MA 02138

Entity Type: 03

Trademark Details

Filing Date

July 23, 2019

Registration Date

Not Registered

Published for Opposition

December 17, 2019

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 20, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 20, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 16, 2022 EXRA
SOU EXTENSION 5 GRANTED
Aug 13, 2022 EX5G
SOU EXTENSION 5 FILED
Aug 11, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 11, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 11, 2022 EXRA
SOU EXTENSION 4 GRANTED
Feb 9, 2022 EX4G
SOU EXTENSION 4 FILED
Feb 9, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 9, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 18, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 18, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 18, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 18, 2021 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2021 EXRA
CORRECTED NOA E-MAILED
Aug 19, 2021 NOAC
SOU EXTENSION 3 GRANTED
Aug 18, 2021 EX3G
DIVISIONAL PROCESSING COMPLETE
Aug 18, 2021 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 18, 2021 AITU
SOU EXTENSION 3 FILED
Aug 11, 2021 EXT3
DIVISIONAL REQUEST RECEIVED
Aug 11, 2021 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Aug 11, 2021 ERTD
SOU TEAS EXTENSION RECEIVED
Aug 11, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2021 EXRA
SOU EXTENSION 2 GRANTED
Feb 11, 2021 EX2G
SOU EXTENSION 2 FILED
Feb 11, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 11, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 11, 2020 EXRA
SOU EXTENSION 1 GRANTED
Aug 7, 2020 EX1G
SOU EXTENSION 1 FILED
Aug 7, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 7, 2020 EEXT
ASSIGNED TO EXAMINER
Jul 23, 2020 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 11, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 17, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2019 NONP
ASSIGNED TO LIE
Nov 12, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 6, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 29, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 29, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 29, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2019 GNRN
NON-FINAL ACTION E-MAILED
Sep 8, 2019 GNRT
NON-FINAL ACTION WRITTEN
Sep 8, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 1, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2019 NWOS
NEW APPLICATION ENTERED
Jul 26, 2019 NWAP

Related Trademarks

More from this Owner

CYTOTIL15

CYTOTIL15

CYTOTIL15

CYTOTIL15

OBSIDIAN THERAPEUTICS

OBSIDIAN THERAPEUTICS

OBSIDIAN THERAPEUTICS

OBSIDIAN THERAPEUTICS

OBSIDIAN

OBSIDIAN

OBSIDIAN

OBSIDIAN